FDA asks how to improve existing Regulations
The U.S. Food and Drug Administration FDA announced that the agency is formally asking for submissions on how to improve existing regulations. FDA expects that retrospective reviews like this would help FDA focus on how to improve regulations.
- Where are regulations ineffective?
- Do regulations address current public health challenges?
- Is there a need to update regulations?
- Can regulations be revised in ways that make them less burdensome without making them less effective?
- Are there regulatory requirements that are redundant, inconsistent or needlessly overlap?
To get more information, go to the FDA Transparency Blog.
Related GMP News
17.09.2025When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025
17.09.2025Dealing with Systems without Audit Trail Functionality
17.09.2025Why is RCA (Root Cause Analysis) so important?
10.09.2025The Use of Hoses in Pharmaceutical Production
10.09.2025Revision of EU-GMP Chapter 1 planned with Consultation Phase
10.09.2025Audit Trail Review by the QP / Dealing with a Lack of Justification